PTH derivatives resistant to skin proteases
OwnerKrishna G. Peri, Kim High +3inventors
InventorsKrishna G. Peri, Kim High, Annie Bergeron, Serge Moffett, Thierry Abribat
Life of this patent
Estimating the term…
Abstract
Protease-resistant analogues of biologically active derivatives of human PTH are described. These analogs are intended for use in therapeutic preparations for the treatment of various medical conditions in which bone loss is encountered or is susceptible of being encountered. The analogs specified are hPTH(1-34) and hPTH(1-31). More particularly, protease-resistant analogs of PTH adapted for transdermal administration are described.
Claims26
A peptide comprising the following sequence:
- 1 H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly- Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu- Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-NHR
- wherein R is selected from the group consisting of a hydrogen atom, lower alkyl, lower alkenyl, substituted lower alkyl, substituted lower alkenyl, lower cycloalkylalkenyl, arylalkyl, substituted arylalkyl, lower arylalkyl, substituted lower arylalkyl, arylalkylenyl, substituted arylalkenyl and heteroarylalkenyl groups:
A peptide comprising the following sequence:
- 2 H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly- Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu- Arg-Lys-Lys-Leu-Gln-Asp-Val-NHR
- wherein R is selected from the group consisting of a hydrogen atom, lower alkyl, lower alkenyl, substituted lower alkyl, substituted lower alkenyl, lower cycloalkylalkenyl, arylalkyl, substituted arylalkyl, lower arylalkyl, substituted lower arylalkyl, arylalkylenyl, substituted arylalkenyl and heteroarylalkenyl groups.
An admixture comprising the peptide as defined in any one of claims 13 to 17 and a or more pharmaceutically acceptable carriers or excipients.
Dependencies are inferred from the claim text.